For participants with type 2 diabetes, the mean diabetes duration was 10.6 ± 8.7 years (range = 1.0 to 49.0 years), the mean BMI was 34.0 ± 8.9 kg/m2 (range = 17.9–83.4 kg/m2), and the distribution of diabetes medications included 45.9% (n = 72) on oral medication(s), 24.2% (n = 38) on insulin and oral medication(s), 14.6% (n = 23) on no medications, 8.9% (n = 14) on insulin, and 6.4% (n = 10) on other medications (e.g., injectables). The gene discussed is INS; the disease is type 2 diabetes mellitus.